ustekinumab
Sandoz announces deal to commercialise biosimilar ustekinumab in Europe and North America
September 11, 2023Research and Development Pharmacy, SB17, Sandoz, commercialisation, ustekinumab
Sandoz has announced that it has entered into a development and commercialisation agreement with Samsung Bioepis, providing Sandoz the exclusive …
Janssen submits Stelara for EU approval for Crohn’s
December 9, 2015Sales and Marketing Crohn’s disease, EMA, European Medicines Agency, Janssen, Stelara, crohn's disease, ustekinumab
Janssen today announced that it has submitted an application to the European Medicines Agency, seeking approval of Stelara in Crohn’s …
Encouraging late-stage results for Stelara in Crohn’s disease
October 21, 2015Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab
Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …
NICE U-turn over Janssen arthritis drug
December 9, 2014Sales and Marketing Janssen, NHS, NICE, Stelara, arthritis, ustekinumab
NICE has reversed its decision on Janssen’s Stelara and is now recommending the active psoriatic arthritis drug. The pricing watchdog …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
